Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Klampfl, K.
Warnke, A.
and
Seifert, J.
2009.
Neuro-Psychopharmaka im Kindes- und Jugendalter.
p.
353.
Deligiannidis, Kristina M.
and
Rothschild, Anthony J.
2010.
The Evidence-Based Guide to Antipsychotic Medications.
p.
45.
Lorenz, Raymond A.
Jackson, Cherry W.
and
Saitz, Marianne
2010.
Adjunctive Use of Atypical Antipsychotics for Treatment‐Resistant Generalized Anxiety Disorder.
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy,
Vol. 30,
Issue. 9,
p.
942.
Lanouette, Nicole M.
and
Stein, Murray B.
2010.
Advances in the Management of Treatment-Resistant Anxiety Disorders.
Focus,
Vol. 8,
Issue. 4,
p.
501.
Lohoff, Falk W.
Etemad, Bijan
Mandos, Laura A.
Gallop, Robert
and
Rickels, Karl
2010.
Ziprasidone Treatment of Refractory Generalized Anxiety Disorder.
Journal of Clinical Psychopharmacology,
Vol. 30,
Issue. 2,
p.
185.
Depping, Anna M
Komossa, Katja
Kissling, Werner
and
Leucht, Stefan
2010.
Second-generation antipsychotics for anxiety disorders.
Cochrane Database of Systematic Reviews,
De Nadai, Alessandro S.
Storch, Eric A.
Mcguire, Joseph F.
Lewin, Adam B.
and
Murphy, Tanya K.
2011.
Evidence-Based Pharmacotherapy for Pediatric Obsessive-Compulsive Disorder and Chronic Tic Disorders.
Journal of Central Nervous System Disease,
Vol. 3,
Issue. ,
p.
JCNSD.S6616.
Katzman, Martin A.
2011.
Aripiprazole: A clinical review of its use for the treatment of anxiety disorders and anxiety as a comorbidity in mental illness.
Journal of Affective Disorders,
Vol. 128,
Issue. ,
p.
S11.
Freire, Rafael C
Hallak, Jaime E
Crippa, José A
and
Nardi, Antonio E
2011.
New treatment options for panic disorder: clinical trials from 2000 to 2010.
Expert Opinion on Pharmacotherapy,
Vol. 12,
Issue. 9,
p.
1419.
Vulink, Nienke C.C.
Figee, Martijn
and
Denys, Damiaan
2011.
Review of atypical antipsychotics in anxiety.
European Neuropsychopharmacology,
Vol. 21,
Issue. 6,
p.
429.
Lalonde, Carlos D.
and
Van Lieshout, Ryan J.
2011.
Treating Generalized Anxiety Disorder With Second Generation Antipsychotics.
Journal of Clinical Psychopharmacology,
Vol. 31,
Issue. 3,
p.
326.
Schwartz, Thomas L.
and
Stahl, Stephen M.
2011.
Treatment Strategies for Dosing the Second Generation Antipsychotics.
CNS Neuroscience & Therapeutics,
Vol. 17,
Issue. 2,
p.
110.
Starcevic, Vladan
and
Hood, Sean
2011.
Treatment-Refractory Generalized Anxiety Disorder.
Psychiatric Annals,
Vol. 41,
Issue. 2,
p.
104.
Batelaan, Neeltje M.
Van Balkom, Anton J. L. M.
and
Stein, Dan J.
2012.
Essential Evidence-Based Psychopharmacology.
p.
73.
Vulink, Nienke C.C.
Figee, Martijn
and
Denys, Damiaan
2012.
Revisión de los antipsicóticos atípicos en la ansiedad.
Psiquiatría Biológica,
Vol. 19,
Issue. ,
p.
21.
Batelaan, Neeltje M.
Van Balkom, Anton J. L. M.
and
Stein, Dan J.
2012.
Evidence-based pharmacotherapy of panic disorder: an update.
The International Journal of Neuropsychopharmacology,
Vol. 15,
Issue. 03,
p.
403.
Buoli, Massimiliano
Caldiroli, Alice
Caletti, Elisabetta
Paoli, Riccardo Augusto
and
Altamura, Alfredo Carlo
2013.
New approaches to the pharmacological management of generalized anxiety disorder.
Expert Opinion on Pharmacotherapy,
Vol. 14,
Issue. 2,
p.
175.
Hershenberg, Rachel
Gros, Daniel F.
and
Brawman-Mintzer, Olga
2014.
Role of Atypical Antipsychotics in the Treatment of Generalized Anxiety Disorder.
CNS Drugs,
Vol. 28,
Issue. 6,
p.
519.
Warnke, Andreas
2014.
Psychiatric Drugs in Children and Adolescents.
p.
359.
Wang, Hee Ryung
Woo, Young Sup
and
Bahk, Won‐Myong
2014.
The potential role of atypical antipsychotics in the treatment of panic disorder.
Human Psychopharmacology: Clinical and Experimental,
Vol. 29,
Issue. 5,
p.
405.